|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 408.6 DKK | -0.90% |
|
-3.65% | +10.11% |
| 05-10 | NOVONESIS : Key segments outperform in average Q1 24 showing |  |
| 05-03 | Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024 |
Novozymes A/S provided earnings guidance for the year 2022. For the year, the company confirmed the 8%-9% full-year organic sales growth outlook.
| 1st Jan change | Capi. | |
|---|---|---|
| +10.11% | 27.6B | |
| -11.53% | 3.9B | |
| +12.25% | 1.83B | |
| -4.30% | 683M | |
| -21.50% | 421M | |
| -81.65% | 216M | |
| -18.97% | 104M | |
| -6.88% | 58.11M |
NOVONESIS A/S 
